Related Experiment Video
Updated: Jun 6, 2026
08:12
Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
Published on: December 22, 2016
Immunotherapy for myeloproliferative neoplasms (MPN)
Susanne Hofmann1, Anna Babiak, Jochen Greiner
1Department of Internal Medicine III, University of Ulm, Germany.
Current Cancer Drug Targets
|November 11, 2010
Summary
Myeloproliferative neoplasms (MPN) encompass four chronic disorders. This review explores current targeted therapies, immunotherapies, and stem cell transplantation options for MPN patients.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Myeloproliferative neoplasms (MPN) are clonal stem cell disorders.
- MPN includes chronic myeloid leukaemia (CML), chronic idiopathic myelofibrosis (CIMF), essential thrombocythemia (ET), and polycythemia vera (PV).
- These conditions are chronic and can progress to myelofibrosis or acute leukemia.
Purpose of the Study:
- To review current therapeutic strategies for myeloproliferative neoplasms (MPN).
- To discuss targeted therapies, immunotherapies, and stem cell transplantation in MPN management.
- To highlight the role of immunotherapy, including vaccination trials, in treating MPN.
Main Methods:
- Review of existing literature on MPN treatments.
- Analysis of targeted therapies like tyrosine kinase inhibitors and JAK2-inhibitors.
- Evaluation of immunotherapeutic approaches including stem cell transplantation, donor lymphocyte infusion, and vaccination strategies.
Main Results:
- Various treatments are available for MPN, including targeted therapies and immunotherapies.
- Allogeneic hematopoietic stem cell transplantation (HSCT) and donor lymphocyte infusion (DLI) are established cellular immunotherapies.
- Vaccination trials using leukaemia-associated antigens (LAAs) are being investigated for CML and BCR-ABL-negative MPNs.
Conclusions:
- Current MPN treatment involves a range of strategies from targeted drugs to cellular immunotherapies.
- The graft-versus-leukaemia (GvL) effect informs the development of specific immunotherapies.
- Further research into immunomodulatory treatments and vaccination holds promise for MPN patients.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...